Window of opportunity to enhance EU regulatory systems wide open as EU pharma strategy prioritises stronger EU networks

Related Posts

• COVID-19 a lightning rod for major overhaul of EU… 9 July 2020 Urgent call for a structured industry-EU dialogue on reform The…
• EU Pharma Strategy: Success depends on access to… 25 November 2020
• Open letter from Medicines for Europe Executive on… 20 October 2020
• Statement from the President: Now or never:… 7 October 2020 Berlin, 07 October 2020, speaking at ‘For a Healthy Europe’,…